A detailed history of Act Capital Management, LLC transactions in Affimed N.V. stock. As of the latest transaction made, Act Capital Management, LLC holds 308,800 shares of AFMD stock, worth $367,472. This represents 0.88% of its overall portfolio holdings.

Number of Shares
308,800
Previous 308,800 -0.0%
Holding current value
$367,472
Previous $855,000 25.61%
% of portfolio
0.88%
Previous 1.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$5.37 - $7.07 $147,675 - $194,425
27,500 Added 9.78%
308,800 $1.71 Million
Q3 2021

Nov 16, 2021

SELL
$5.54 - $7.51 $34,902 - $47,313
-6,300 Reduced 2.19%
281,300 $1.74 Million
Q2 2021

Aug 16, 2021

BUY
$7.78 - $11.4 $2.24 Million - $3.28 Million
287,600 New
287,600 $2.45 Million

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $178M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.